Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Healthcare Medical Devices

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc > Rapid Antigen Tests

<< Previous

Bullboard Posts

Next >>

Comment by baggerx99on Apr 10, 2021 11:02am

223 Views

Post# 32972538

RE:Rapid Antigen Tests

Toronto, Ontario--(Newsfile Corp. - March 23, 2021) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the "Company" or "Datametrex") is pleased to announce that Heath Canada ("HC") has approved the PCL Inc.'s ("PCL") COVID19 AG Rapid test kit ("PCL Antigen"), an antigen point-of-care rapid test device under the Interim Order ("IO") Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19.

Smokey1958 wrote:
Rapid Antigen tests approved for use in Brazil (Anvisa) up to this date require a blood or nasopharyngeal sample and thus must be carried out in a lab setting and/or by a medical professional (expensive). The most recent device was approved in January so no new approval(s) in over 2 months.

No new device approved by HC since February and nothing new on the list for companies applying for review in months. There is a very strong sense that kids in Ontario may not be going back to school after their "March Break" this week. A covid test to combat these measures was needed "yesterday".

Unfortunately cases are climbing in almost every corner of the planet and yet NO Rapid Antigen Test seems to have met the expectation, demand and absolute need for mass testing ....and as such very few governments have embraced it. In spite of opinions to the contrary AcuVid appears to be the only test device with any sign of promise.

While it would be a great day for shareholders to see positive results from Brazil and a quick turn around when making their application to HC ....the more important reason is fast becoming because the WORLD needs to find a way to stem the tide. Add to that, the rate of vaccinations in the developing world is abysmal ....and there is no sign of that changing any time soon.

HOPEfully the results from Brazil will come out early next week.

Be safe and have a great weekend!!!